Premium
BENDAMUSTINE‐RITUXIMAB (BR) VERSUS R‐CHOP AS UPFRONT THERAPY FOR INDOLENT B‐CELL LYMPHOMAS: A COMPARATIVE, POPULATION‐BASED ANALYSIS
Author(s) -
Olszewski A.J.,
Castillo J.J.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2438_82
Subject(s) - medicine , bendamustine , rituximab , population , diffuse large b cell lymphoma , febrile neutropenia , follicular lymphoma , oncology , surgery , lymphoma , neutropenia , chemotherapy , environmental health